Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Expert Opinion on Drug Safety|October 20, 2011
Web-based intensive monitoring: from passive to active drug surveillanceLinda Härmark, Kees van Grootheest
Pharmacoepidemiology and Drug Safety|May 4, 2011
Longitudinal monitoring of the safety of drugs by using a web-based system: the case of pregabalinLinda Härmark, Eugene Puijenbroek, Kees Grootheest
Expert Opinion on Drug Safety|April 30, 2019
Fifteen years of patient reporting -what have we learned and where are we heading to?Florence van Hunsel, Linda Härmark, Leàn Rolfes
Drug Safety|May 13, 2014
Experiences with the use of varenicline in daily practice in the Netherlands: a prospective, observational cohort studyIngrid Oosterhuis, Linda Härmark, Eugène van Puijenbroek
Drug Safety|January 29, 2015
ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish SystemsLinda Härmark, Florence van Hunsel, Birgitta Grundmark
European Journal of Clinical Pharmacology|March 19, 2017
A global view of undergraduate education in pharmacovigilanceJenny Hartman, Linda Härmark, Eugène van Puijenbroek
Drug Safety|September 2, 2016
Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities' Views and NeedsCristiano Matos, Linda Härmark, Florence van Hunsel
Pharmacoepidemiology and Drug Safety|May 20, 2017
The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015Florence van Hunsel, Susan de Waal, Linda Härmark
Pageof 5